Defense Advanced Research Projects AgencyTagged Content List

Infectious Disease

Relating to ailments caused by pathogens

Showing 4 results for Disease + Manufacturing RSS
The Nucleic acids On-demand Worldwide (NOW) program aims to develop a mobile medical countermeasure (MCM) manufacturing platform for use in stabilization and humanitarian operations to rapidly produce, formulate, and package hundreds of doses of nucleic acid therapeutics (DNA and/or RNA).
Program Manager
Dr. Amy Jenkins joined DARPA as a program manager in the Biological Technologies Office (BTO) in June 2019. Her interests include the development of platforms for combatting infectious disease threats as well as novel manufacturing methods to enable rapid response.
09/03/2018
Our deployed service members are exposed to adversary activity and numerous naturally occurring or engineered threats including chemicals, viruses, and bacteria. To protect them, BTO is developing technologies that can rapidly detect and characterize these threats. In addition, BTO is developing novel biological approaches to sense and report adversary activities on land and at sea.
08/28/2020
Service members need constant supplies of clean water, food, medicines, and materials to complete their missions. BTO is enabling the migration of biotechnology from the lab into the field, creating new opportunities to harden operations against disruption by increasing operational resilience and logistic security.